Cargando…
Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
Reduction of LDL-cholesterol concentration in serum, blocking the isoprenylation of GTPases and the activation of myocyte-protective enzyme systems are three mechanisms that currently explain the lipid and non-lipid effects of statins. However, the decrease of LDL-cholesterol, the reduction of infla...
Autores principales: | Morales-Villegas, Enrique C., Di Sciascio, Germano, Briguori, Carlo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065660/ https://www.ncbi.nlm.nih.gov/pubmed/21461336 http://dx.doi.org/10.4061/2011/904742 |
Ejemplares similares
-
Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016) -
Effect of Previous Statin Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2011) -
Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
por: Cerit, L., et al.
Publicado: (2016) -
Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naïve Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Kim, Min Chul, et al.
Publicado: (2019) -
Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
por: Bin Abdulhak, Aref A., et al.
Publicado: (2018)